BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 11953991)

  • 21. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
    Mukherjee P; Yang SY; Wu B; Song Z; Myers LK; Robbins PD; Wooley PH
    Ann Rheum Dis; 2005 Nov; 64(11):1550-6. PubMed ID: 15860512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis.
    Chu CQ; Londei M
    J Autoimmun; 1999 Feb; 12(1):35-42. PubMed ID: 10028020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular responses of bioabsorbable polymeric material and Guglielmi detachable coil in experimental aneurysms.
    Murayama Y; Viñuela F; Tateshima S; Gonzalez NR; Song JK; Mahdavieh H; Iruela-Arispe L
    Stroke; 2002 Apr; 33(4):1120-8. PubMed ID: 11935070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of collagen-induced arthritis (CIA) by treatment with polyethylene glycol-conjugated type II collagen; distinct tolerogenic property of the conjugated collagen from the native one.
    Ito HO; So T; Ueda T; Imoto T; Koga T
    Clin Exp Immunol; 1997 May; 108(2):213-9. PubMed ID: 9158088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice.
    Santos LM; al-Sabbagh A; Londono A; Weiner HL
    Cell Immunol; 1994 Sep; 157(2):439-47. PubMed ID: 7520838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection.
    Fargnoli AS; Mu A; Katz MG; Williams RD; Margulies KB; Weiner DB; Yang S; Bridges CR
    J Transl Med; 2014 Jun; 12():171. PubMed ID: 24934216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation.
    Yang Z; Birkenhauer P; Julmy F; Chickering D; Ranieri JP; Merkle HP; Lüscher TF; Gander B
    J Control Release; 1999 Aug; 60(2-3):269-77. PubMed ID: 10425332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis.
    Mukherjee P; Wu B; Mayton L; Kim SH; Robbins PD; Wooley PH
    Ann Rheum Dis; 2003 Aug; 62(8):707-14. PubMed ID: 12860724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early events associated to the oral co-administration of type II collagen and chitosan: induction of anti-inflammatory cytokines.
    Porporatto C; Bianco ID; Cabanillas AM; Correa SG
    Int Immunol; 2004 Mar; 16(3):433-41. PubMed ID: 14978017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis.
    Higuchi K; Kweon MN; Fujihashi K; McGhee JR; Kiyono H
    J Rheumatol; 2000 Apr; 27(4):1038-44. PubMed ID: 10782834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's patch M cells.
    Ermak TH; Dougherty EP; Bhagat HR; Kabok Z; Pappo J
    Cell Tissue Res; 1995 Feb; 279(2):433-6. PubMed ID: 7895280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and characterisation of new nanoparticulate polymer blends for drug delivery.
    Csaba N; González L; Sánchez A; Alonso MJ
    J Biomater Sci Polym Ed; 2004; 15(9):1137-51. PubMed ID: 15503631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model.
    Bäcklund J; Nandakumar KS; Bockermann R; Mori L; Holmdahl R
    J Immunol; 2003 Oct; 171(7):3493-9. PubMed ID: 14500645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of orally administered polystyrene latex and poly(D,L-lactic/glycolic acid) microspheres into intestinal lymphoid tissues in chickens.
    Hoshi S; Uchino A; Kusanagi K; Ihara T; Ueda S
    Vet Immunol Immunopathol; 1999 Sep; 70(1-2):33-42. PubMed ID: 10507285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and characterization of a poly(lactic-co-glycolic acid) core + poly(N-isopropylacrylamide) shell nanoparticle system.
    Kosinski AM; Brugnano JL; Seal BL; Knight FC; Panitch A
    Biomatter; 2012; 2(4):195-201. PubMed ID: 23507885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses.
    Wang JX; Tang W; Zhou R; Wan J; Shi LP; Zhang Y; Yang YF; Li Y; Zuo JP
    Br J Pharmacol; 2008 Mar; 153(6):1303-10. PubMed ID: 18264129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility.
    Bertram JP; Jay SM; Hynes SR; Robinson R; Criscione JM; Lavik EB
    Acta Biomater; 2009 Oct; 5(8):2860-71. PubMed ID: 19433141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.
    Yoo HS; Oh JE; Lee KH; Park TG
    Pharm Res; 1999 Jul; 16(7):1114-8. PubMed ID: 10450940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of functions and tissue compatibility of poly (D,L-lactic-co-glycolic acid) seeded with human dermal fibroblasts.
    Yang WS; Roh HW; Lee WK; Ryu GH
    J Biomater Sci Polym Ed; 2006; 17(1-2):151-62. PubMed ID: 16411605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.